Rodolphe Thiebaut
Overview
Explore the profile of Rodolphe Thiebaut including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
241
Citations
6844
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Nunes M, Thommes E, Frohlich H, Flahault A, Arino J, Baguelin M, et al.
Infect Dis Model
. 2024 Mar;
9(2):501-518.
PMID: 38445252
In July 2023, the Center of Excellence in Respiratory Pathogens organized a two-day workshop on infectious diseases modelling and the lessons learnt from the Covid-19 pandemic. This report summarizes the...
12.
Ganser I, Buckeridge D, Heffernan J, Prague M, Thiebaut R
Epidemics
. 2024 Feb;
46:100744.
PMID: 38324970
Background: Non-pharmaceutical interventions (NPIs) and vaccines have been widely used to manage the COVID-19 pandemic. However, uncertainty persists regarding the effectiveness of these interventions due to data quality issues, methodological...
13.
Alexandre M, Prague M, McLean C, Bockstal V, Douoguih M, Thiebaut R
NPJ Vaccines
. 2023 Nov;
8(1):174.
PMID: 37940656
The persistence of the long-term immune response induced by the heterologous Ad26.ZEBOV, MVA-BN-Filo two-dose vaccination regimen against Ebola has been investigated in several clinical trials. Longitudinal data on IgG-binding antibody...
14.
Choi E, Lacarra B, Afolabi M, Ale B, Baiden F, Betard C, et al.
Lancet Glob Health
. 2023 Oct;
11(11):e1743-e1752.
PMID: 37858585
Background: This study assessed the safety and immunogenicity of the Ad26.ZEBOV and MVA-BN-Filo Ebola virus (EBOV) vaccine regimen in infants aged 4-11 months in Guinea and Sierra Leone. Methods: In...
15.
Blengio F, Hocini H, Richert L, Lefebvre C, Durand M, Hejblum B, et al.
Cell Rep
. 2023 Sep;
42(9):113101.
PMID: 37691146
Ebola virus disease is a severe hemorrhagic fever with a high fatality rate. We investigate transcriptome profiles at 3 h, 1 day, and 7 days after vaccination with Ad26.ZEBOV and...
16.
Clairon Q, Prague M, Planas D, Bruel T, Hocqueloux L, Prazuck T, et al.
PLoS Comput Biol
. 2023 Aug;
19(8):e1011282.
PMID: 37549192
Because SARS-CoV-2 constantly mutates to escape from the immune response, there is a reduction of neutralizing capacity of antibodies initially targeting the historical strain against emerging Variants of Concern (VoC)s....
17.
Thiebaut R, Hejblum B, Mougin F, Tzourio C, Richert L
Joint Bone Spine
. 2023 Jul;
90(5):105607.
PMID: 37414138
No abstract available.
18.
Zysman M, Asselineau J, Saut O, Frison E, Oranger M, Maurac A, et al.
Eur Radiol
. 2023 Jul;
33(12):9262-9274.
PMID: 37405504
Objectives: COVID-19 pandemic seems to be under control. However, despite the vaccines, 5 to 10% of the patients with mild disease develop moderate to critical forms with potential lethal evolution....
19.
McLean C, Barry H, Kieh M, Anywaine Z, Tapima Rogers B, Doumbia S, et al.
EBioMedicine
. 2023 Apr;
91:104562.
PMID: 37099841
Background: This analysis evaluated the immune response to the two-dose, heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola virus vaccine regimen, administered 56-days apart, from multiple African sites based on results from one analytic...
20.
Riviere E, Thiebaut R, Lazaro E, Guy A, James C, Mansier O, et al.
Br J Haematol
. 2023 Apr;
202(1):159-167.
PMID: 37081607
Immune thrombocytopenia (ITP) is defined by a low platelet count that can trigger potentially life-threatening haemorrhages. Three-quarters of adult patients exhibit persistent or chronic disease and require second-line treatments. Among...